Kinase inhibitor
US8927563B2 · kind B2 · utility
37Cited by
18References
6Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Apr 1, 2014 |
| Grant date | Jan 6, 2015 |
| Priority date | — |
| Expiry date | Apr 1, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a compound of formula I,which compound has antiinflammatory activity (e.g. through inhibition of one or more of members of: the family of p38 mitogen-activated protein kinase enzymes; Syk kinase; and members of the Src family of tyrosine kinases, e.g., Src and Lck) and has use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, eye and intestines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.